336 results on '"Soliman, Pamela T."'
Search Results
2. Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma
3. Perioperative outcomes in gynecologic pelvic exenteration before and after implementation of an enhanced recovery after surgery program
4. Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center
5. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities
6. Is Hormonal Therapy the Best Therapy for Chemo-resistant Endometrial Cancer?
7. Isolated vaginal recurrence in women with stage I endometrial cancer
8. Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers
9. Feasibility of using the handheld MasSpec pen technology for intraoperative identification of ovarian cancer during tumor reductive surgery.
10. Gemcitabine plus cisplatin in recurrent ovarian, fallopian tube, and primary peritoneal cancer.
11. Oral cyclophosphamide plus bevacizumab in recurrent ovarian, fallopian tube and primary peritoneal cancer.
12. Unlocking success: Multidisciplinary rounds for effective discharge planning.
13. Clinical and genomic landscape of RAS mutations in gynecologic cancers
14. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas
15. Abstract A077: The utility of surgical minimal residual disease after frontline treatment for prognostic and investigational opportunities in advanced ovarian cancer
16. Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer
17. Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer
18. Malignant diseases of the uterus
19. List of contributors
20. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II
21. When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic
22. Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients With Ovarian Cancer Receiving Carboplatin-Based Chemotherapy
23. Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial
24. Public Knowledge of Obesity and Gynecologic Cancer Risk
25. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
26. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience
27. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer
28. Prognostic factors impacting survival in early stage uterine carcinosarcoma
29. Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer
30. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer.
31. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer
32. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities
33. A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice
34. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration
35. Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers
36. Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer
37. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer
38. Factors prognostic of survival in advanced-stage uterine serous carcinoma
39. Potential immunotherapy targets in recurrent cervical cancer
40. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer
41. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia
42. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges
43. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study
44. Figure_S6 from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
45. Supplementary Figure 2 from Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study
46. Supplementary Figure 1 from Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study
47. Supplementary Tables from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
48. Supplementary materials from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
49. Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer
50. Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.